Immunogenicity, safety and efficacy of COVID-19 vaccine: Correspondence

被引:0
|
作者
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj [1 ,2 ]
机构
[1] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria
[2] Dr DY Patil Univ, Pune, Maharashtra, India
关键词
Immunogenicity; Safety; Ef ficacy; COVID-19; Vaccine;
D O I
10.1016/j.ijmmb.2023.100387
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
    Nurpeisova, Ainur
    Khairullin, Berik
    Abitaev, Ruslan
    Shorayeva, Kamshat
    Jekebekov, Kuanish
    Kalimolda, Elina
    Kerimbayev, Aslan
    Akylbayeva, Karligash
    Abay, Zhandos
    Myrzakhmetova, Balzhan
    Nakhanov, Aziz
    Absatova, Zharkinay
    Nurabayev, Sergazy
    Orynbayev, Mukhit
    Assanzhanova, Nurika
    Abeuov, Khairulla
    Kutumbetov, Lespek
    Kassenov, Markhabat
    Abduraimov, Yergaly
    Zakarya, Kunsulu
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [2] The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
    Yang, Lei
    Liu, YaMing
    Guo, Qiao
    Jiang, DePeng
    [J]. OPEN MEDICINE, 2023, 18 (01):
  • [3] Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
    Frenck, Robert W., Jr.
    Klein, Nicola P.
    Kitchin, Nicholas
    Gurtman, Alejandra
    Absalon, Judith
    Lockhart, Stephen
    Perez, John L.
    Walter, Emmanuel B.
    Senders, Shelly
    Bailey, Ruth
    Swanson, Kena A.
    Ma, Hua
    Xu, Xia
    Koury, Kenneth
    Kalina, Warren V.
    Cooper, David
    Jennings, Timothy
    Brandon, Donald M.
    Thomas, Stephen J.
    Tureci, Ozlem
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03): : 239 - 250
  • [4] Correspondence on 'COVID-19 vaccine efficacy in a rapidly changing landscape'
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (06) : 1442 - 1442
  • [5] Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease"
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (10) : E142 - E142
  • [6] Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
    Asghar, Neelam
    Mumtaz, Hassan
    Syed, Abdul Ahad
    Eqbal, Farea
    Maharjan, Reeju
    Bamboria, Aditya
    Shrehta, Manish
    [J]. IMMUNOLOGICAL MEDICINE, 2022, 45 (04) : 225 - 237
  • [7] COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
    Fendler, Annika
    de Vries, Elisabeth G. E.
    GeurtsvanKessel, Corine H.
    Haanen, John B.
    Wormann, Bernhard
    Turajlic, Samra
    von Lilienfeld-Toal, Marie
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 385 - 401
  • [8] COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
    Annika Fendler
    Elisabeth G. E. de Vries
    Corine H. GeurtsvanKessel
    John B. Haanen
    Bernhard Wörmann
    Samra Turajlic
    Marie von Lilienfeld-Toal
    [J]. Nature Reviews Clinical Oncology, 2022, 19 : 385 - 401
  • [9] Methotrexate and COVID-19 vaccine immunogenicity
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (07): : E479 - E479
  • [10] Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine
    Rabdano, Sevastyan
    Ruzanova, Ellina
    Makarov, Denis
    Vertyachikh, Anastasiya
    Teplykh, Valeriya
    Rudakov, German
    Pletyukhina, Iuliia
    Saveliev, Nikita
    Zakharov, Konstantin
    Alpenidze, Diana
    Vasilyuk, Vasiliy
    Arakelov, Sergei
    Skvortsova, Veronika
    [J]. VACCINES, 2024, 12 (01)